What is Milestone Scientific Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Milestone Scientific's interest expense for the
three
months ended in Mar. 2024 was $ -0.00 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.00 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Milestone Scientific's Operating Income for the
three
months ended in Mar. 2024 was $ -1.47 Mil. Milestone Scientific's Interest Expense for the
three
months ended in Mar. 2024 was $ -0.00 Mil.
Milestone Scientific did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Milestone Scientific Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Milestone Scientific (AMEX:MLSS) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Milestone Scientific's Interest Expense for the
three
months ended in Mar. 2024 was $-0.00 Mil. Its
Operating Income
for the
three
months ended in Mar. 2024 was $-1.47 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Mar. 2024 was $0.25 Mil.
Milestone Scientific's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as
| Milestone Scientific did not have earnings to cover the interest expense. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Milestone Scientific (Milestone Scientific) Business Description
Traded in Other Exchanges
N/A
Address
425 Eagle Rock Avenue, Roseland, NJ, USA, 07068
Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.
Executives
| Peter J Milligan |
officer: President |
1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102 |
| Neal I Goldman |
director |
170 SOUTHPORT DRIVE, MORRISVILLE NC 27560 |
| Leslie Bernhard |
director |
C/O ADSTAR, INC., 488 S. ROYAL LANE, COPPELL TX 75019 |
| Benedetta I Casamento |
director |
200 CAMPUS DRIVE, FLORHAM PARK NJ 07932 |
| Leonard Osser |
director, 10 percent owner, officer: CEO |
|
| Leonard M Schiller |
director |
|
| Scott L. Kahn |
officer: Chief Financial Officer |
425 EAGLE ROCK AVENUE, SUITE 403, ROSELAND NJ 07068 |
| Giandomenico Trombetta |
director, 10 percent owner |
CORSO VENEZIA 44, MILAN L6 20121 |
| Joseph D'agostino |
officer: CFO & COO |
C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039 |
| Jan Adriaan Haverhals |
officer: President |
110 WHITE ROCK ROAD, APT. 3304, VERONA NJ 07044 |
| Brent W Johnston |
officer: President |
C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE SUITE 102, LIVINGSTON NJ 07039 |
| Michael Mcgeehan |
director |
C/O MILESTONE SCIENTIFIC INC, LIVINGSTON NJ 07039 |
| Edward J. Zelnick |
director |
C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039 |
| Daniel S Goldberger |
officer: President and CEO |
24 CARPENTER ROAD, CHESTER NY 10918 |
| Bp4 S.r.l. |
director, 10 percent owner, officer: See Remarks |
CORSO VENEZIA 44, MILAN L6 20121 |
Milestone Scientific (Milestone Scientific) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MLSS has been successfully added to your 